Hematopoietic Growth Factors in the Management of Anemia and Febrile Neutropenia

Chemotherapy-induced anemia (CIA) in cancer patients correlates with poor performance status and decreased quality of life. Currently recommended causal therapies are erythropoiesis-stimulating agents (epoetins), iron substitution, or a combination of both. Guidelines recommend considering red blood cell (RBC) transfusions for symptomatic anemia at a hemoglobin (Hb) level of
Source: Breast Care - Category: Cancer & Oncology Source Type: research